Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 211 results found. Search for [ Zydus Cadila Healthcare ]

Results 1 to 21 of 211
BusinessToday.In
October 19, 2020
India Stock Market Highlights Today: ONGC, followed by NTPC, HDFC, Axis Bank, ICICI Bank, PowerGrid and Nestle India were among the top gainer on Sensex pack. On the other hand, TCS, Tech Mahindra, Infosys and Sun Pharma were among the laggards.


BusinessToday.In
October 17, 2020
The shots planned for the initial phase would include a booster dose as well. The list comprises four categories of beneficiaries including frontline workers, healthcare professionals, people above 50, and people with comorbidities


BusinessToday.In
October 16, 2020
Cadila Healthcare share gained up to 3.99% to Rs 432.20 against previous close of Rs 415.60 on BSE


BusinessToday.In
October 16, 2020
Ivermectin, a drug used to treat lice and other parasites, has shown some promising results against coronavirus, claims a specialist from Melbourne


BusinessToday.In
October 5, 2020
Stocks to watch today on October 5: Angel Broking, RIL, TCS, NMDC, Dr Reddy's among others are the top stocks to watch out for in Monday's trading session


BusinessToday.In
September 25, 2020
India Stock Market News Updates Today: IndusInd Bank, M&M, TCS, Bajaj Finance, Bharti Airtel, Sun Pharma, Maruti, Tata Steel and Axis Bank were among the top gainers on Sensex pack. Kotak Bank wa the only loser.


PTI
September 22, 2020
A vaccine is definitely needed to control the spread of this disease, but the vaccine alone is not enough, and other efforts such as social distancing, wearing mask, isolating and testing people will continue to remain important


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


BusinessToday.In
August 17, 2020
Last month, the medical journal Lancet wrote that the Phase-2 clinical trial of CanSino Biologics' adenovirus vector vaccine or Ad5-nCoV was safe and induced immune response


BusinessToday.In
August 8, 2020
Coronavirus vaccine update: Serum Institute of India might begin its Phase 2 and 3 clinical trials in India within a week. Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate are going on in the United Kingdom, phase 3 clinical trial in Brazil


Joe C Mathew
August 3, 2020
Indian vaccine manufacturers are waiting for a vaccination plan from the government so that they can set aside stocks of vaccines when they are approved for production


BusinessToday.In
July 24, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates:  The study showed that curcumin can prevent Transmissible gastroenteritis virus (TGEV)- an alpha-group coronavirus that infects pigs, from infecting cells. The higher doses of curcumin were also found to kill virus particles


BusinessToday.In
July 20, 2020
Covaxin is being jointly developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology and is India's first indigenously developed COVID-19 vaccine candidate


BusinessToday.In
July 17, 2020
Share price of Cadila Health gained up to 4.86% to Rs 378.5 against previous close of Rs 360.95


BusinessToday.In
July 17, 2020
Coronavirus vaccine news update: Zydus Cadila Chairman Pankaj Patel has said that he expects a potential COVID vaccine to be out in the market by early next year


PTI
July 16, 2020
ZyCoV-D and COVAXIN, developed by city-based Bharat Biotech in collaboration with Indian Council of Medical Research, are the only two vaccine candidates to have got a nod from the drug regulatory body to conduct human trials


BusinessToday.In
July 16, 2020
Coronavirus vaccine news: Lakshmi Mittal said that the importance of dedicated and ongoing research in this field cannot be overestimated


BusinessToday.In
July 15, 2020
The rupee opened at 75.35 per dollar, and later gained further ground to touch 75.28 per dollar, up 14 paise over its previous close of 75.42 on Tuesday


BusinessToday.In
July 15, 2020
Stock Market Highlights on July 15: Infosys, Axis Bank, Tech Mahindra, Bajaj Finance, Tata Steel, HCL Tech and IndusInd Bank were among the other gainers on Sensex. On the other hand, Bharti Airtel, ITC and Kotak Bank were the laggards


Mudit Kapoor and Ashish Pandey
New Delhi, July 14, 2020
Sun Pharma, Dr Reddy's Laboratories, Cipla, Torrent Pharmaceuticals, Lupin and Cadila Healthcare have given over 50 per cent return since January 30 when the first coronavirus case was reported


PAGES 1 OF 11  12345